Pages that link to "Q44245742"
Jump to navigation
Jump to search
The following pages link to High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load (Q44245742):
Displaying 50 items.
- Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region (Q26750444) (← links)
- Current and future directions for treating hepatitis B virus infection (Q26851240) (← links)
- Hepatitis B virus treatment beyond the guidelines: special populations and consideration of treatment withdrawal (Q26995814) (← links)
- Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments (Q27008984) (← links)
- Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy (Q27022899) (← links)
- Prevention of hepatocellular carcinoma in patients with chronic hepatitis B (Q27023997) (← links)
- Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients (Q28066959) (← links)
- Recent advances in understanding and diagnosing hepatitis B virus infection (Q28067419) (← links)
- Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma (Q28080175) (← links)
- Virus-induced hepatocellular carcinoma with special emphasis on HBV. (Q30238961) (← links)
- Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis (Q30251618) (← links)
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (Q30391932) (← links)
- Viral hepatitis and hepatocellular carcinoma: etiology and management (Q33593219) (← links)
- Hepatitis B virus infection and alcohol consumption (Q33599503) (← links)
- Add-on Pegylated Interferon Alpha-2a Therapy in Chronic Hepatitis B Japanese Patients Treated with Entecavir (Q33604145) (← links)
- Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma (Q33661054) (← links)
- Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia (Q33661164) (← links)
- Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL. (Q33686951) (← links)
- Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma (Q33736377) (← links)
- Large variations in risk of hepatocellular carcinoma and mortality in treatment naïve hepatitis B patients: systematic review with meta-analyses (Q34203972) (← links)
- Risk stratification of HBV infection in Asia-Pacific region. (Q34339577) (← links)
- Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma (Q34343960) (← links)
- High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B. (Q34391308) (← links)
- AASLD guidelines for treatment of chronic hepatitis B. (Q34501660) (← links)
- Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection (Q34598267) (← links)
- The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy. (Q34785355) (← links)
- Viral hepatitis B: clinical and epidemiological characteristics (Q34930389) (← links)
- HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication (Q34998266) (← links)
- Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients (Q35105157) (← links)
- Level of hepatitis B surface antigen might serve as a new marker to predict hepatocellular carcinoma recurrence following curative resection in patients with low viral load (Q35402699) (← links)
- Models for predicting hepatitis B e antigen seroconversion in response to interferon-α in chronic hepatitis B patients (Q35594289) (← links)
- Hepatitis B virus genotypes and variants. (Q35663838) (← links)
- Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues (Q35668724) (← links)
- Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels (Q35876187) (← links)
- Cell death and cell death responses in liver disease: mechanisms and clinical relevance (Q35938040) (← links)
- Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay (Q36037164) (← links)
- Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function (Q36217581) (← links)
- Platelet counts modulate the quantitative relationship between hepatitis B viral DNA and surface antigen concentrations: a cross-sectional study of hematological, histological and viral factors (Q36240894) (← links)
- Elimination of Hepatitis B: Is It a Mission Possible? (Q36307834) (← links)
- Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk (Q36619079) (← links)
- Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7. (Q36691039) (← links)
- Virus and Host Testing to Manage Chronic Hepatitis B. (Q36958940) (← links)
- Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog. (Q36973383) (← links)
- Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and women (Q37176658) (← links)
- Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection. (Q37207070) (← links)
- Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy. (Q37241565) (← links)
- Enhanced HBsAg synthesis correlates with increased severity of fibrosis in chronic hepatitis B patients (Q37538710) (← links)
- New perspectives of biomarkers for the management of chronic hepatitis B. (Q37606546) (← links)
- Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy (Q37716237) (← links)
- Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application (Q37727852) (← links)